BIO-key receives Nasdaq non-compliance notice for late 10-Q filing
BIO-key International received a notice from Nasdaq stating the company failed to timely file its Form 10-Q for the quarter ended March 31, 2026, violating Listing Rule 5250(c)(1). The Nasdaq Hearing Panel will determine whether the company maintains its listing on Nasdaq Capital Market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day